Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
cns demyelinating autoimmune diseases
MeSH D020278 - cns demyelinating autoimmune diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D020274:
Autoimmune diseases of the nervous system
1 Company
1 Drug
$
Success rate
D003711:
Demyelinating diseases
0 Companies
0 Drugs
Success rate
D056784:
Leukoencephalopathies
0 Companies
0 Drugs
Success rate
D020278:
Cns demyelinating autoimmune diseases
0 Companies
0 Drugs
Success rate
D002549:
Diffuse cerebral sclerosis of schilder
0 Companies
0 Drugs
Success rate
D004673:
Acute disseminated encephalomyelitis
0 Companies
0 Drugs
Success rate
D009103:
Multiple sclerosis
157 Companies
33 Drugs
$
Success rate
D009188:
Transverse myelitis
30 Companies
1 Drug
$
Success rate
D009471:
Neuromyelitis optica
3 Companies
2 Drugs
$
Success rate
D004681:
Autoimmune encephalomyelitis experimental
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
0
%
0/0
Approved:
0
Overall Success rate:
0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use